Delivery Order SPE2DB22D3010-SPE2DB24FP3GT

Award Date 9/17/24
Potential Completion Date 9/18/24
Potential Value $9.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of the medication Mounjaro (tirzepatide) 7.5 mg/0.5 mL pen. The $35,119.82 firm fixed-price delivery order has a period of performance through November 12, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of the drug Mounjaro (tirzepatide) 15 mg/0.5 ml pen. The $3,897.84 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which provides a wide range of medical commodities to support military healthcare programs....
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of the medication Mounjaro (tirzepatide) 10 mg/0.5 mL pens. The award, valued at $1,578, is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) worth up to $999,999,999. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
The U.S. Defense Logistics Agency (DLA) awarded a $9,954.88 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of the drug Mounjaro (tirzepatide) 5 mg/0.5 mL pens. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for supplying a comprehensive range of pharmaceutical products and medical...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $11,422.80, is for the supply of the prescription medication Mounjaro (tirzepatide) 10 mg/0.5 ml pens. This order does not have a set-aside designation, indicating open competition. The DLA is the funding agency for this contract, which supports the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,081.35 Firm Fixed Price Delivery Order covers the supply of the medication Mounjaro (Tirzepatide) 10 mg/0.5 ml pen in a 0.5 ml quantity. The contract has an ultimate completion date of December 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, is for the supply of the drug Mounjaro (generic name: tirzepatide) in a 15 mg/0.5 mL pen dosage form. The award, valued at $1,113.05, is a delivery order issued by the Defense Logistics Agency (DLA), a defense agency responsible for providing logistics and technical services to the U.S. Armed Forces. The contract is a firm-fixed price arrangement with a completion date of June 26, 2024....
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of the medication Mounjaro (tirzepatide) 7.5 mg/0.5 ml pens. The contract has a firm fixed price of $5,189.64 and a completion date of August 1, 2024. This is a delivery order contract, which is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025 between AmerisourceBergen and the DLA...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of the medication Mounjaro (tirzepatide) 7.5 mg/0.5 ml pens. The $1,578 Firm Fixed Price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. The contract has an ultimate completion date of August 5, 2024 and does not utilize any set-aside designations. As a large medical supplier, Amerisourcebergen has...
The U.S. Defense Logistics Agency (DLA) awarded a $9,319.47 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of the prescription drug Mounjaro (tirzepatide) 5 mg/0.5 mL pens. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, which serves as the primary vehicle for Amerisourcebergen...
  • SPE2DB22D3010
    Indefinite Delivery Contract
  • SPE2DB22D3010-SPE2DB24FP3GT
    Delivery Order

This federal contract award is to Amerisourcebergen Drug Corporation's Corporate Office Division, a major pharmaceutical distributor, to supply the Defense Logistics Agency (DLA) Troop Support Medical with the drug Mounjaro (Tirzepatide) 10 mg/0.5 mL pens. The delivery order is valued at $9,226.10 and has a completion date of September 18, 2024. This contract is not set aside for a specific business type. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide.

Generated 12/17/24, 9:04 AM